CLINICAL RESEARCH: NON-CARDIAC FINDINGS AND CORONARY ATHEROSCLEROSIS
Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation
Harish R. Chandra, MD, MPH*,
James A. Goldstein, MD*,
Nivedita Choudhary, MD, MPH*,
Carol S. O'Neill, RN, BSN*,
Peter B. George, MD*,
Sreenivasulu R. Gangasani, MD*,
Lynn Cronin, MD*,
Pamela A. Marcovitz, MD*,
Andrew M. Hauser, MD* and
William W. O'Neill, MD*,*
* Division of Cardiology, Department of Internal Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA
Manuscript received February 26, 2003;
revised manuscript received July 23, 2003,
accepted August 25, 2003.
* Reprint requests and correspondence: Dr. William W. O'Neill, Director, Division of Cardiology, William Beaumont Hospital, 3601 W. 13 Mile Road, Royal Oak, Michigan 48073, USA. woneill{at}beaumont.edu
Presented in parts as an abstract at the American College of Cardiology Scientific Sessions in March 2001 and the American Heart Association Scientific Sessions in November 2000.
OBJECTIVES: The present study was designed to evaluate the relationship between the presence of aortic sclerosis, serologic markers of inflammation, and adverse cardiovascular outcomes.
BACKGROUND: Aortic sclerosis is associated with adverse cardiovascular outcomes. However, the mechanism by which such nonobstructive valve lesions impart excess cardiovascular risk has not been delineated.
METHODS: In 425 patients (mean age 68 ± 15 years, 54% men) presenting to the emergency room with chest pain, we studied the relationship among aortic sclerosis, the presence and acuity of coronary artery disease, serologic markers of inflammation, and cardiovascular outcomes. Patients underwent echocardiography and serologic testing including C-reactive protein (CRP). Aortic valves were graded for the degree of sclerosis, and cardiovascular outcomes including cardiac death and nonfatal myocardial infarction (MI) were analyzed over one year.
RESULTS: Aortic sclerosis was identified in 203 patients (49%) , whereas 212 (51%) had normal aortic valves. On univariate analysis at one year, patients with aortic sclerosis had a higher incidence of cardiovascular events (16.8% vs. 7.1%, p = 0.002) and worse event-free survival (normal valves = 93%, mild aortic sclerosis = 85%, and moderate to severe aortic sclerosis = 77%, p = 0.002). However, by multivariable analysis aortic sclerosis was not independently associated with adverse cardiovascular outcomes; the only independent predictors of cardiac death or MI at one year were coronary artery disease (hazard ratio [HR] 3.23, p = 0.003), MI at index admission (HR 2.77, p = 0.008), ascending tertiles of CRP (HR 2.2, p = 0.001), congestive heart failure (HR 2.15, p = 0.02) and age (HR 1.03, p = 0.04).
CONCLUSIONS: The increased incidence of adverse cardiovascular events in patients with aortic sclerosis is associated with coronary artery disease and inflammation, not a result of the effects of valvular heart disease per se.
|
Abbreviations and Acronyms
| | CAD | = coronary artery disease | | CRP | = C-reactive protein | | ECG | = electrocardiogram | | IgG | = immunoglobulin G | | MI | = myocardial infarction |
|
This article has been cited by other articles:

|
 |

|
 |
 
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation,
October 7, 2008;
118(15):
e523 - e661.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
September 23, 2008;
52(13):
e1 - e142.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Toutouzas, M. Drakopoulou, A. Synetos, E. Tsiamis, G. Agrogiannis, N. Kavantzas, E. Patsouris, D. Iliopoulos, S. Theodoropoulos, M. Yacoub, et al.
In Vivo Aortic Valve Thermal Heterogeneity in Patients With Nonrheumatic Aortic Valve Stenosis: The First In Vivo Experience in Humans
J. Am. Coll. Cardiol.,
August 26, 2008;
52(9):
758 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Carabello
Aortic Stenosis: It Is a Hot Topic: The Link to Coronary Artery Disease
J. Am. Coll. Cardiol.,
August 26, 2008;
52(9):
764 - 766.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Messika-Zeitoun, L. F. Bielak, P. A. Peyser, P. F. Sheedy, S. T. Turner, V. T. Nkomo, J. F. Breen, J. Maalouf, C. Scott, A. J. Tajik, et al.
Aortic Valve Calcification: Determinants and Progression in the Population
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2007;
27(3):
642 - 648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
e1 - e148.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
598 - 675.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A K Nightingale and J D Horowitz
Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk
Heart,
November 1, 2005;
91(11):
1389 - 1393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. V. Freeman and C. M. Otto
Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies
Circulation,
June 21, 2005;
111(24):
3316 - 3326.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Rahimtoola
The year in valvular heart disease
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
111 - 122.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al.
Highlights of the year in JACC 2004
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
137 - 153.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Systolic murmur in an asymptomatic 70 year old man
Heart,
January 1, 2005;
91(1):
125 - 125.
[Full Text]
[PDF]
|
 |
|
|